Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy

Background Data from the 3 omalizumab pivotal trials in patients with chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) represent the largest database of patients reported to date with refractory disease (omalizumab, n = 733; placebo, n = 242). Objective The objective of this stud...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2015-09, Vol.3 (5), p.743-750.e1
Hauptverfasser:	Casale, Thomas B., MD, Bernstein, Jonathan A., MD, Maurer, Marcus, MD, Saini, Sarbjit S., MD, Trzaskoma, Benjamin, MS, Chen, Hubert, MD, Grattan, Clive E., MA, MD, FRCP, Gimenéz-Arnau, Ana, MD, PhD, Kaplan, Allen P., MD, Rosén, Karin, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergies Allergy and Immunology Analysis of Variance Antihistamine Asterias Asthma Chronic Disease Chronic idiopathic Chronic spontaneous Clinical trials Confidence intervals Dermatology Drug Dosage Calculations Drug Therapy, Combination Female Follow-Up Studies Histamine H1 Antagonists - administration & dosage Histamine H1 Antagonists - adverse effects Histamine H2 Antagonists - administration & dosage Histamine H2 Antagonists - adverse effects Hive Humans Immunotherapy - methods Internal Medicine Itch Male Middle Aged Omalizumab Omalizumab - administration & dosage Omalizumab - adverse effects Pruritus Recurrence Studies Treatment Outcome Urticaria Urticaria - immunology Urticaria - therapy Wheal
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!